These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 2506803

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Comparison of ampicillin-sulbactam with vancomycin for treatment of experimental endocarditis due to a beta-lactamase-producing, highly gentamicin-resistant isolate of Enterococcus faecalis.
    Lavoie SR, Wong ES, Coudron PE, Williams DS, Markowitz SM.
    Antimicrob Agents Chemother; 1993 Jul; 37(7):1447-51. PubMed ID: 8363374
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Contribution of animal models in the search for effective therapy for endocarditis due to enterococci with high-level resistance to gentamicin.
    Eliopoulos GM, Thauvin-Eliopoulos C, Moellering RC.
    Clin Infect Dis; 1992 Jul; 15(1):58-62. PubMed ID: 1319757
    [Abstract] [Full Text] [Related]

  • 7. Antibiotic treatment of experimental endocarditis due to vancomycin- and ampicillin-resistant Enterococcus faecium.
    Whitman MS, Pitsakis PG, Zausner A, Livornese LL, Osborne AJ, Johnson CC, Levison ME.
    Antimicrob Agents Chemother; 1993 Oct; 37(10):2069-73. PubMed ID: 8257125
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Therapeutic efficacy of teicoplanin in experimental enterococcal endocarditis.
    Sullam PM, Täuber MG, Hackbarth CJ, Sande MA.
    Antimicrob Agents Chemother; 1985 Jan; 27(1):135-6. PubMed ID: 3157344
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Sparfloxacin and clinafloxacin alone or in combination with gentamicin for therapy of experimental ampicillin-resistant enterococcal endocarditis in rabbits.
    Vazquez J, Perri MB, Thal LA, Donabedian SA, Zervos MJ.
    J Antimicrob Chemother; 1993 Nov; 32(5):715-21. PubMed ID: 8125836
    [Abstract] [Full Text] [Related]

  • 17. Antibiotic synergism in enterococcal endocarditis.
    Carrizosa J, Kaye D.
    J Lab Clin Med; 1976 Jul; 88(1):132-41. PubMed ID: 819602
    [Abstract] [Full Text] [Related]

  • 18. Activity of LY146032 in vitro and in experimental enterococcal pyelonephritis.
    Miniter PM, Patterson TF, Johnson MA, Andriole VT.
    Antimicrob Agents Chemother; 1987 Aug; 31(8):1199-203. PubMed ID: 2820299
    [Abstract] [Full Text] [Related]

  • 19. Aortic endocarditis caused by gentamicin-resistant Enterococcus faecalis.
    Fernández-Guerrero ML, Barros C, Rodriguez Tudela JL, Fernández Roblas R, Soriano F.
    Eur J Clin Microbiol Infect Dis; 1988 Aug; 7(4):525-7. PubMed ID: 3141162
    [Abstract] [Full Text] [Related]

  • 20. Beta-Lactam-beta-lactamase-inhibitor combinations are active in experimental endocarditis caused by beta-lactamase-producing oxacillin-resistant staphylococci.
    Hirano L, Bayer AS.
    Antimicrob Agents Chemother; 1991 Apr; 35(4):685-90. PubMed ID: 2069374
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.